Revolution Medicines, Inc. (RVMD)
142.45
-8.62
(-5.71%)
USD |
NASDAQ |
May 07, 16:00
142.53
+0.08
(+0.06%)
After-Hours: 20:00
Revolution Medicines Research and Development Expense (Annual) : 978.68M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tango Therapeutics, Inc. | 129.88M |
| AtriCure, Inc. | 90.17M |
| Eli Lilly & Co. | 13.34B |
| Travere Therapeutics, Inc. | 206.01M |
| Kymera Therapeutics, Inc. | 308.26M |